Sun exposure, sunscreens, and skin cancer prevention: A year-round concern

Annals of Pharmacotherapy

Volumn 30, Issue 6, 1996, Pages 662-672

  Farmer, Kevin C ^a   Naylor, Mark F ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BENZOYL PEROXIDE; CARDIOVASCULAR AGENT; COAL TAR; GOLD SALT; MINOXIDIL; PSORALEN; RETINOIC ACID; SUNSCREEN; TOPICAL AGENT;

ACTINIC KERATOSIS; AGING; ANTIINFLAMMATORY ACTIVITY; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CARDIOVASCULAR FUNCTION; DISEASE ASSOCIATION; DOSE RESPONSE; EARLY DIAGNOSIS; FOOD AND DRUG ADMINISTRATION; HUMAN; MALIGNANT LENTIGO; MELANOMA; NEVUS; PHOTOSENSITIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEBORRHEA; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET RADIATION;

CLINICAL TRIALS; HUMANS; SKIN AGING; SKIN NEOPLASMS; SUNLIGHT; SUNSCREENING AGENTS; ULTRAVIOLET RAYS; UNITED STATES;

EID: 0029899010     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000615     Document Type: Article

References (87)

1. Whiteman D, Green A. Melanoma and sunburn. Cancer Causes Control 1994;5:564-72.
2. Lober CW, Fenske NA. Photoaging and the skin: differentiation and clinical response. Geriatrics 1990;45:36-42.
3. Taylor CR, Stern RS, Leyden JJ, Gilchrest BA. Photoaging/photodamage and photoprotection. J Am Acad Dermatol 1990;22:1-15.
4. Young AR. Cumulative effects of ultraviolet radiation on the skin: cancer and photoaging. Semin Dermatol 1990;9:25-31.
5. Yaar M, Gilchrest BA. Cellular and molecular mechanisms of cutaneous aging. J Dermatol Surg Oncol 1990;16:915-22.
6. Chase M. Tan worshippers may be giving skin lots more than glow. Wall Street Journal 1995 June 5: section B, column 1.
7. Sambuco CP. Miniature swine as an animal model in photodermatology: factors influencing sunburn cell formation. Photodermatology 1985;2: 144-50.
8. Gallagher CH, Canfield PJ, Greenoak GE, Reeve VE. Characterization and histogenesis of tumors in the hairless mouse produced by low-dosage incremental ultraviolet radiation. J Invest Dermatol 1984;83:169-74.
9. Leipold B, Remy W. Use of avidin-biotin-peroxidase complex for measurement of UV lesions in human DNA by microELISA. J Immunol Methods 1984;66:227-34.
10. Fourtanier A, Berrebi C. Miniature pig as an animal model to study photoaging. Photochem Photobiol 1989;50:771-84.
11. Environmental health criteria 160: ultraviolet radiation. WHO. Environmental health criteria. Vammala, Finland: World Health Organization, 1994:352.
12. Lydahl E, Philipson B. Infrared radiation and cataract. I. Epidemiologic investigation of iron and steel workers. Acta Ophthalmol 1984;62:961-75.
13. Lydahl E. Infrared radiation and cataract. Acta Ophthalmol 1984;166 (suppl):1-63.
14. Lydahl E, Philipson B. Infrared radiation and cataract II. Epidemiologic investigation of glass workers. Acla Ophthalmol 1984;62:976-92.
15. Jones CS, Tyring SK, Lee PC, Fine ID. Development of neuroendocrine (Merkel cell) carcinoma mixed with squamous cell carcinoma in erythema ab igne. Arch Dermatol 1988;124:110-3.
16. Akasaka T, Kon S. Two cases of squamous cell carcinoma arising from erythema ab igne. J Dermatol 1989;99:735-42.
17. Arlington JH, Lockman DS. Thermal keratoses and squamous cell carcinoma in situ associated with erythema ab igne. Arch Dermatol 1979; 115:1226-8.
18. Kligman LH. Intensification of ultraviolet-induced dermal damage by infrared radiation. Arch Dermatol Res 1982;272:229-38.
19. Kligman LH. Photoaging. Manifestations, prevention, and treatment. Dermatol Clin 1986;4:517-28.
20. Sams WJ. Sun-induced aging. Clinical and laboratory observations in humans. Clin Geriatr Med 1989;5:223-33.
21. Griffiths CE. The clinical identification and quantification of photodamage. Br J Dermatol 1992;127(suppl 41):37-42.
22. Robinson ES, VandeBerg JL, Hubbard GB, Dooley TP. Malignant melanoma in ultraviolet irradiated laboratory opossums: initiation in sucking young, metastasis in adults, and xenograft behavior in nude mice. Cancer Res 1994;54:5986-91.
23. Maenpaa J, Dooley T, Wurz G, VandeBerg JL, Robinson ES, Emshoff V, et al. Topical toremifene: a new approach for cutaneous melanoma? Cancer Chemother Pharmacol 1993;32:392-5.
24. Kusewitt DF, Applegate LA, Bucana CD, Ley RD. Naturally occurring malignant melanoma in the South American opossum (monodelphis domestica). Vet Pathol 1990;27:66-8.
25. Setlow RB, Woodhead AD. Temporal changes in the incidence of malignant melanoma: explanation from action spectra. Mutat Res 1994; 307:365-74.
26. Surveillance, epidemiology, and end results (SEER). Cancer statistics review 1973-1991. National Cancer Institute, 1995:66-9.
27. Pal S. Melanoma shows steady rise. US Pharm 1995;20(4):14.
28. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
29. Weinstock MA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 1993;129:1286-90.
30. Kopf AW, Kripke ML, Stern RS. Sun and malignant melanoma. J Am Acad Dermatol 1984; 11 (4 pt 1):674-84.
31. Swerdlow AJ. Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. Br Med J 1979;2:1324-7.
32. Magnus K. Incidence of malignant melanoma of the skin in Norway 1955-1970. Variations in time and space and solar radiation. Cancer 1973;32:1275-86.
33. Eklund G, Malec E. Sunlight and incidence of cutaneous malignant melanoma. Effect of latitude and domicile in Sweden. Scand J Plast Reconstr Surg 1978;12:231-41.
34. Teppo L, Pakkanen M, Hakulinsen T. Sunlight as a risk factor of malignant melanoma of the skin. Cancer 1978;41:2018-27.
35. Elwood JM, Lee JA, Walter SD, Mo T, Green AE, Relationship of melanoma and other skin cancer mortality to latitude and ultraviolet radiation in the United States and Canada. Int J Epidemiol 1974;3:325-32.
36. Scotto J, Fears TR. The association of solar ultraviolet and skin melanoma incidence among Caucasians in the United States, Cancer Invest 1987;5:275-83.
37. Pitcher HM, Longstreth JD. Melanoma mortality and exposure to ultraviolet radiation: an empirical relationship. Environ Int 1991;17:7-21.
38. Fears TR, Scotto J, Schneiderman MA. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 1977;105:420-7.
39. Muir C, Waterhouse J, Mack T, Powell J, Whelan J. Cancer incidence in five continents. No 88 ed. Lyon: IARC Scientific Publications, 1987:40-4.
40. Whelan SL, Parkin DM, Masuyer E. Patterns of cancer in five continents. No 102 ed. Lyon: IARC Scientific Publications, 1990:29-32.
41. Cannon-Albright LA, Meyer LJ, Goldgar DE. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 1994;54:6041-4.
42. Richard MA, Grob JJ, Gouvemet J. Role of sun exposure on nevus. First study in age-sex phenotype-controlled populations. Arch Dermatol 1993; 129:1280-5.
43. Garbe C, Buttner P, Weiss J. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Registry of the German Dermatological Society. J Invest Dermatol 1994;102:700-5.
44. Tiersten AD, Grin CM, Kopf AW. Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndrome. J Dermatol Surg Oncol 1991;17:44-8.
45. Marghoob AA, Kopf AW, Rigel DS. Risk of malignant melanoma for patients with "classic" atypical-mole syndrome. Melanoma Lett 1994; 12:1-2.
46. Slade J, Marghoob AA, Salopek TG. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol 1995;32:479-94.
47. Crombie IK. Distribution of malignant melanoma on the body surface area. Br J Cancer 1981;43:842-9.
48. Elwood JM, Gallagher RP. Site distribution of malignant melanoma. Can Med Assoc J 1983;128:1400-4.
49. Larue L, Dougherty N, Mintz B. Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytes. Proc Natl Acad Sci U S A 1992;89:9534-8.
50. Setlow RB, Woodhead AD, Grist E. Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid. Proc Natl Acad Sci USA 1989;86:8922-6.
51. Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A 1993;90:6666-70.
52. World Health Organization. Evaluation of carcinogenic risks to humans. Intl Agency Res Cancer Monogr 1992;55:100-12.
53. Swerdlow AJ, English JS, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, et al. Fluorescent light, ultraviolet lamps, and the risk of cutaneous melanoma. Br Med J 1988;297:647-50.
54. Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol 1990;131:23243.
55. Freeman RG. Data on the action spectrum for ultraviolet carcinogenesis. J Natl Cancer Inst 1975;55:1119-22.
56. de Gruijl FR, Sterenborg HJ, Forbes PD, Davies RE, Cole C, Kelfkens G, et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res 1993;53:53-60.
57. Morton DL, Davtyan DC, Wanek LA, Foshag LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43.
58. Naylor MF, Boyd A, Smith DW, Cameron GS. Hubbard D, Neldner KH. High sun protection factor sunscreens in the supression of actinic neoplasia. Arch Dermatol 1995;131:170-5.
59. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;329:1147-51.
60. Diffey BL, Larko O. Clinical climatology. Photodermatology 1984;1:30-7.
61. Stiller MJ, Davis IC, Shupack JL, A concise guide to topical sunscreens: state of the art. Int J Dermatol 1992;31:540-3.
62. Sterling GB. Sunscreens: a review. Cutis 1992;50:221-4.
63. DeSimone EM. FDA proposes changes in sunscreen regulations. Am Pharm 1994;NS34:26-31.
64. Drug facts and comparisons. St Louis, MO: Facts and Comparisons, 1995:562a.
65. Bissett DL, McBride JF, Hannon DP. Time-dependent decrease in sunscreen protection against chronic photodamage in UVB-irradiated hairless mouse skin. J Photochem Photobiol B 1991;9:323-34.
66. Odio M, Veres D, Goodman J. Comparative efficacy of sunscreen reapplication regimens in children exposed to ambient sunlight. Photodermatol Photoimmunol Photomed 1994;10:118-25.
67. Zaynoun S, Anderson RR. Cumulative effects of repeated subthreshold doses of ultraviolet radiation. J Invest Dermatol 1981;76:356-8.
68. Kaidbey KH. The photoprotective potential of the new superpotent sunscreens. J Am Acad Dermatol 1990;22:449-52.
69. Ziegler A, Jonason AS, Leftell DJ, Simon JA, Sharma HW, Kimmelman J, et al. Sunburn and p53 in the onset of skin cancer. Nature 1994;372: 773-6.
70. van Weelden H, van der Putte SC, Toonstra J, van der Leun JC. UVA-induced tumours in pigmented hairless mice and the carcinogenic risks of tanning with UVA. Arch Dermatol Res 1990;282:289-94.
71. Bech-Thomsen N, Poulsen T, Christensen FG, Lundgren K, Wulf HC. UVA tanning devices interact with solar-simulated UV radiation in skin tumor development in hairless mice. Arch Dermatol Res 1992;284:353-7.
72. Kelfkens G, de Gruijl FR, van der Leim JC. Tumorigenesis by short-wave ultraviolet A: papillomas versus squamous cell carcinomas. Carcinogenesis 1991;12:1377-82.
73. Talve L, Stenback F, Jansen CT. UVA irradiation increases the incidence of epithelial tumors in UVB-irradiated hairless mice. Photodermatol Photoimmunol Photomed 1990;7:109-15.
74. Eller MS, Yaar M, Gilchrest BA. DNA damage and melanogenesis. Nature 1994;372:413-4.
75. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1995;124:869-71.
76. Potter TS, Hashimoto K. Cutaneous photosensitivity to medications. Compr Ther 1994;20:414-7.
77. Allen JE. Drug-induced photosensitivity. Clin Pharm 1993;12:580-7.
78. Engle JP. Choosing sunscreen products. Am Druggist 1995;212(2):36.
79. Mailloux AT. Photosensitivity and burns. In: Young LY, Koda-Kimble MA, eds. Applied therapeutics: the clinical use of drugs. 6th ed. Vancouver, WA: Applied Therapeutics, Inc., 1995:39-1-39-15.
80. Urbach F. Sunscreen not mutagenic (letter). Med J Aust 1980;2:284.
81. Bonin AM, Arlauskas AP, Angus DS, Baker RS, Gallagher CH, Greenoak G, et al. UV-absorbing and other sun-protecting substances: genotoxicity of 2-ethylhexyl p-methoxycinnamate. Mutat Res 1982;105:303-8.
82. Henderson L, Fedyk J, Bourner C, Windebank S, Fletcher S, Lovell W. Photomutagenicity assays in bacteria: factors affecting assay design and assessment of photomutagenic potential of para-aminobenzoic acid. Mutagenesis 1991;9:459-65.
83. Dean SW, Lane M, Dunmore RH, Ruddock SP, Martin CN, Kirkland DJ, et al. Development of assays for the detection of photomutagenicity of chemicals during exposure to UV lighl-I. Assay development. Mutagenesis 1991;6:335-41.
84. Gichner T, Baburek I, Veleminshy J, Kappas A. UV-irradiation potentiates the antimutagenicity of p-aminobenzoic and p-aminosalicylic acids in Salmonella typhimurium. Mutat Res 1991;249:119-23.
85. Knowland J, McKenzie EA, McHugh PJ, Cridland NA. Sunlight-induced mutagenicity of a common sunscreen ingredient. FEBS Lett 1993; 324:309-13.
86. Mondon P, Shahin MM. Protective effect of two sunscreens against lethal and genotoxic effects of UVB in V79 Chinese hamster cells and Saccharomvces cerevisiae strains XVI85-14C and D5. Mutat Res 1992; 279:121-8.
87. Gallagher CH, Greenoak GE, Reeve VE, Canfield PJ, Baker RS, Bonin AM. Ultraviolet carcinogenesis in the hairless mouse skin: influence of the sunscreen 2-ethylhexyl-p-methoxycinnamate. Aust J Exp Biol Med Sci 1984;62(pt5):577-88.